CS logo
small CS logo
Amarillo Center For Clinical Research

Amarillo, Texas, United States

About Amarillo Center For Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Eli Lilly and Company
3
Janssen Research & Development, LLC
3
R-Pharm International, LLC
3
Bristol-Myers Squibb
2
Genentech, Inc.
2
Novartis
2
Pfizer
2
Avalo Therapeutics, Inc.
1
BeiGene
1
Chiesi Farmaceutici S.p.A.
1
Total Rows: 19

Clinical Trials at Amarillo Center For Clinical Research


During the past decade, Amarillo Center For Clinical Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 13 clinical trials were completed, i.e. on average, 68.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22112233114455110000440011113333Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
2002-04-01
2003-08-01
Completed
Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate
2003-09-01
2006-04-01
Completed
300
Study of LJP 394 in Lupus Patients With History of Renal Disease
2004-10-01
2009-02-01
Terminated
943
Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis
2005-05-01
2005-12-01
Completed
360
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain
2004-04-01
2005-08-01
Terminated
418
Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis
2006-11-01
2007-06-01
Completed
420
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
2007-05-15
2018-05-14
Terminated
836
Dose Finding Study of CHF 4226 for Treating Patients With COPD
2006-10-01
2007-06-01
Completed
278

Rows per page:

1–33 of 33

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Amarillo Center For Clinical Research" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Amarillo Center For Clinical Research" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 5Hoffmann-La Roche: 5Eli Lilly and Company: 3Eli Lilly and Company: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3R-Pharm International, LLC: 3R-Pharm International, LLC: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Genentech, Inc.: 2Genentech, Inc.: 2Novartis: 2Novartis: 2Pfizer: 2Pfizer: 2Avalo Therapeutics, Inc.: 1Avalo Therapeutics, Inc.: 1BeiGene: 1BeiGene: 1

Created with Highcharts 11.1.0Top CollaboratorsIncyte Corporation: 3Incyte Corporation: 3OCT Clinical Trials: 3OCT Clinical Trials: 3Quintiles, Inc.: 2Quintiles, Inc.: 2Chiesi USA, Inc.: 1Chiesi USA, Inc.: 1Hexal AG: 1Hexal AG: 1IQVIA Pvt. Ltd: 1IQVIA Pvt. Ltd: 1Mene Research: 1Mene Research: 1Roche Pharma AG: 1Roche Pharma AG: 1

Clinical Trials Conditions at Amarillo Center For Clinical Research


According to Clinical.Site data, the most researched conditions in "Amarillo Center For Clinical Research" are "Rheumatoid Arthritis" (14 trials), "Systemic Lupus Erythematosus" (6 trials), "Lupus Erythematosus, Systemic" (2 trials), "Lupus Nephritis" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "Amarillo Center For Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Amarillo Center For Clinical Research


Most popular intervention types in "Amarillo Center For Clinical Research" are "Drug" (30 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Baricitinib" (3 trials), "Methotrexate" (3 trials), "Methylprednisolone" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Amarillo Center For Clinical Research


The vast majority of trials in "Amarillo Center For Clinical Research" are 33 trials for "All" genders.

Clinical Trials Status at Amarillo Center For Clinical Research


Currently, there are NaN active trials in "Amarillo Center For Clinical Research". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Amarillo Center For Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Amarillo Center For Clinical Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 19Phase 3: 19Phase 2: 9Phase 2: 9Phase 4: 5Phase 4: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 17Completed: 17Recruiting: 8Recruiting: 8Terminated: 7Terminated: 7Active, not recruiting: 1Active, not recruiting: 1